| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |